Sign In

Login

Password

Forgot Password ? Sign Up

TLR9 (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "TLR9" in Czech language version.

Last modified:

Ref.Un. Ref.Website
Global rank Czech rank
1815worldcat.org
4th place
2nd place
1815doi.org
2nd place
4th place
1111nih.gov
5th place
8th place
33dovepress.com
low place
low place
31biomedcentral.com
2,731st place
549th place
22frontiersin.org
3,332nd place
610th place
21liebertpub.com
8,924th place
4,397th place
11e-cmh.org
low place
low place
11begellhouse.com
low place
low place
11jimmunol.org
low place
2,970th place
11elsevier.com
365th place
150th place
11ajandrology.com
low place
low place
11plos.org
2,101st place
340th place
11wiley.com
150th place
67th place

ajandrology.com (Global: low place; Czech: low place)

  • ZENG, Xian-Zi; HUANG, Zhan-Sen; FANG, Hong-Peng. Coexpression of TLR9 and VEGF-C is associated with lymphatic metastasis in prostate cancer. Asian Journal of Andrology. 2022, roč. 0, čís. 0, s. 0. Dostupné online [cit. 2022-04-28]. ISSN 1008-682X. doi:10.4103/aja202167. (anglicky)

begellhouse.com (Global: low place; Czech: low place)

dl.begellhouse.com

biomedcentral.com (Global: 2,731st place; Czech: 549th place)

translational-medicine.biomedcentral.com

  • BAI, Ling; CHEN, Wei; CHEN, Jingtao. Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application. Journal of Translational Medicine. 2017-12, roč. 15, čís. 1, s. 51. Dostupné online [cit. 2022-04-28]. ISSN 1479-5876. doi:10.1186/s12967-017-1152-5. (anglicky)

doi.org (Global: 2nd place; Czech: 4th place)

  • JEONG, Soung Won. Toll-like receptor 9, a possible blocker of non-alcoholic steatohepatitis?. Clinical and Molecular Hepatology. 2020-04-01, roč. 26, čís. 2, s. 185–186. Dostupné online [cit. 2022-04-28]. ISSN 2287-2728. doi:10.3350/cmh.2020.0046. (anglicky)
  • BECK, Stacy; BUHIMSCHI, Irina A.; SUMMERFIELD, Taryn L. Toll-like receptor 9, maternal cell-free DNA and myometrial cell response to CpG oligodeoxynucleotide stimulation. American Journal of Reproductive Immunology (New York, N.Y.: 1989). 2019-04, roč. 81, čís. 4, s. e13100. PMID: 30758898 PMCID: PMC6453711. Dostupné online [cit. 2022-04-28]. ISSN 1600-0897. doi:10.1111/aji.13100. PMID 30758898.
  • SONG, Ying; SHOU, Li Meng; AI, Li-Yao. Mini-Review: The Non-Immune Functions of Toll-Like Receptors. Critical Reviews in Eukaryotic Gene Expression. 2019, roč. 29, čís. 1, s. 37–45. Dostupné online [cit. 2022-04-28]. ISSN 1045-4403. doi:10.1615/CritRevEukaryotGeneExpr.2018027399. (anglicky)
  • SINHA, Siddhartha S.; CAMERON, Jody; BROOKS, James C. Complex Negative Regulation of TLR9 by Multiple Proteolytic Cleavage Events. The Journal of Immunology. 2016-08-15, roč. 197, čís. 4, s. 1343–1352. Dostupné online [cit. 2022-04-28]. ISSN 0022-1767. doi:10.4049/jimmunol.1502357. PMID 27421483. (anglicky)
  • FUKUI, Ryutaro; YAMAMOTO, Chikako; MATSUMOTO, Fumi. Cleavage of Toll-Like Receptor 9 Ectodomain Is Required for In Vivo Responses to Single Strand DNA. Frontiers in Immunology. 2018-06-27, roč. 9, s. 1491. Dostupné online [cit. 2022-04-28]. ISSN 1664-3224. doi:10.3389/fimmu.2018.01491. PMID 29997629.
  • BAI, Ling; CHEN, Wei; CHEN, Jingtao. Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application. Journal of Translational Medicine. 2017-12, roč. 15, čís. 1, s. 51. Dostupné online [cit. 2022-04-28]. ISSN 1479-5876. doi:10.1186/s12967-017-1152-5. (anglicky)
  • DIAS, André Alves; SILVA, Carlos Adriano de Matos e; SILVA, Camila Oliveira da. TLR-9 Plays a Role in Mycobacterium leprae-Induced Innate Immune Activation of A549 Alveolar Epithelial Cells. Frontiers in Immunology. 2021-08-12, roč. 12, s. 657449. Dostupné online [cit. 2022-04-28]. ISSN 1664-3224. doi:10.3389/fimmu.2021.657449. PMID 34456901.
  • MARTÍNEZ-CAMPOS, Cecilia; BURGUETE-GARCÍA, Ana I.; MADRID-MARINA, Vicente. Role of TLR9 in Oncogenic Virus-Produced Cancer. Viral Immunology. 2017-03, roč. 30, čís. 2, s. 98–105. Dostupné online [cit. 2022-04-28]. ISSN 0882-8245. doi:10.1089/vim.2016.0103. (anglicky)
  • HAN, Sang Jun; WILLIAMS, Ryan M.; D’AGATI, Vivette. Selective nanoparticle-mediated targeting of renal tubular Toll-like receptor 9 attenuates ischemic acute kidney injury. Kidney International. 2020-07, roč. 98, čís. 1, s. 76–87. Dostupné online [cit. 2022-04-28]. doi:10.1016/j.kint.2020.01.036. PMID 32386967. (anglicky)
  • ZENG, Xian-Zi; HUANG, Zhan-Sen; FANG, Hong-Peng. Coexpression of TLR9 and VEGF-C is associated with lymphatic metastasis in prostate cancer. Asian Journal of Andrology. 2022, roč. 0, čís. 0, s. 0. Dostupné online [cit. 2022-04-28]. ISSN 1008-682X. doi:10.4103/aja202167. (anglicky)
  • CHANDLER, Madison R.; KEENE, Kimberly S.; TUOMELA, Johanna M. Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans. PLOS ONE. 2017-09-08, roč. 12, čís. 9, s. e0183832. Dostupné online [cit. 2022-04-28]. ISSN 1932-6203. doi:10.1371/journal.pone.0183832. PMID 28886076. (anglicky)
  • CAI, Yongqing; HUANG, Jian; XING, Haiyan. Contribution of FPR and TLR9 to hypoxia-induced chemoresistance of ovarian cancer cells. OncoTargets and Therapy. 2018-12-28, roč. 12, s. 291–301. Dostupné online [cit. 2022-04-28]. doi:10.2147/OTT.S190118. PMID 30643427. (anglicky)
  • GAO, Caixia; QIAO, Tiankui; YUAN, Sujuan. The Preliminary Study for Postoperative Radiotherapy Survival Associated with RUNX3 and TLR9 Expression in Lung Cancer. Cancer Management and Research. 2021-06, roč. Volume 13, s. 4497–4507. Dostupné online [cit. 2022-04-28]. ISSN 1179-1322. doi:10.2147/CMAR.S305452. (anglicky)
  • WEI, Jingjing; WU, Di; ZHAO, Songsong. Immunotherapy of Malignant Glioma by Noninvasive Administration of TLR9 Agonist CpG Nano‐Immunoadjuvant. Advanced Science. 2022-03-07, s. 2103689. Dostupné online [cit. 2022-04-28]. ISSN 2198-3844. doi:10.1002/advs.202103689. (anglicky)
  • WANG, Shu; ZHUANG, Xibing; GAO, Caixia. Expression of p16, p53, and TLR9 in HPV-Associated Head and Neck Squamous Cell Carcinoma: Clinicopathological Correlations and Potential Prognostic Significance. OncoTargets and Therapy. 2021-02, roč. Volume 14, s. 867–877. Dostupné online [cit. 2022-04-28]. ISSN 1178-6930. doi:10.2147/OTT.S293163. PMID 33574680. (anglicky)

dovepress.com (Global: low place; Czech: low place)

  • CAI, Yongqing; HUANG, Jian; XING, Haiyan. Contribution of FPR and TLR9 to hypoxia-induced chemoresistance of ovarian cancer cells. OncoTargets and Therapy. 2018-12-28, roč. 12, s. 291–301. Dostupné online [cit. 2022-04-28]. doi:10.2147/OTT.S190118. PMID 30643427. (anglicky)
  • GAO, Caixia; QIAO, Tiankui; YUAN, Sujuan. The Preliminary Study for Postoperative Radiotherapy Survival Associated with RUNX3 and TLR9 Expression in Lung Cancer. Cancer Management and Research. 2021-06, roč. Volume 13, s. 4497–4507. Dostupné online [cit. 2022-04-28]. ISSN 1179-1322. doi:10.2147/CMAR.S305452. (anglicky)
  • WANG, Shu; ZHUANG, Xibing; GAO, Caixia. Expression of p16, p53, and TLR9 in HPV-Associated Head and Neck Squamous Cell Carcinoma: Clinicopathological Correlations and Potential Prognostic Significance. OncoTargets and Therapy. 2021-02, roč. Volume 14, s. 867–877. Dostupné online [cit. 2022-04-28]. ISSN 1178-6930. doi:10.2147/OTT.S293163. PMID 33574680. (anglicky)

e-cmh.org (Global: low place; Czech: low place)

  • JEONG, Soung Won. Toll-like receptor 9, a possible blocker of non-alcoholic steatohepatitis?. Clinical and Molecular Hepatology. 2020-04-01, roč. 26, čís. 2, s. 185–186. Dostupné online [cit. 2022-04-28]. ISSN 2287-2728. doi:10.3350/cmh.2020.0046. (anglicky)

elsevier.com (Global: 365th place; Czech: 150th place)

linkinghub.elsevier.com

  • HAN, Sang Jun; WILLIAMS, Ryan M.; D’AGATI, Vivette. Selective nanoparticle-mediated targeting of renal tubular Toll-like receptor 9 attenuates ischemic acute kidney injury. Kidney International. 2020-07, roč. 98, čís. 1, s. 76–87. Dostupné online [cit. 2022-04-28]. doi:10.1016/j.kint.2020.01.036. PMID 32386967. (anglicky)

frontiersin.org (Global: 3,332nd place; Czech: 610th place)

jimmunol.org (Global: low place; Czech: 2,970th place)

liebertpub.com (Global: 8,924th place; Czech: 4,397th place)

  • MARTÍNEZ-CAMPOS, Cecilia; BURGUETE-GARCÍA, Ana I.; MADRID-MARINA, Vicente. Role of TLR9 in Oncogenic Virus-Produced Cancer. Viral Immunology. 2017-03, roč. 30, čís. 2, s. 98–105. Dostupné online [cit. 2022-04-28]. ISSN 0882-8245. doi:10.1089/vim.2016.0103. (anglicky)

nih.gov (Global: 5th place; Czech: 8th place)

ncbi.nlm.nih.gov

  • BECK, Stacy; BUHIMSCHI, Irina A.; SUMMERFIELD, Taryn L. Toll-like receptor 9, maternal cell-free DNA and myometrial cell response to CpG oligodeoxynucleotide stimulation. American Journal of Reproductive Immunology (New York, N.Y.: 1989). 2019-04, roč. 81, čís. 4, s. e13100. PMID: 30758898 PMCID: PMC6453711. Dostupné online [cit. 2022-04-28]. ISSN 1600-0897. doi:10.1111/aji.13100. PMID 30758898.
  • SINHA, Siddhartha S.; CAMERON, Jody; BROOKS, James C. Complex Negative Regulation of TLR9 by Multiple Proteolytic Cleavage Events. The Journal of Immunology. 2016-08-15, roč. 197, čís. 4, s. 1343–1352. Dostupné online [cit. 2022-04-28]. ISSN 0022-1767. doi:10.4049/jimmunol.1502357. PMID 27421483. (anglicky)
  • FUKUI, Ryutaro; YAMAMOTO, Chikako; MATSUMOTO, Fumi. Cleavage of Toll-Like Receptor 9 Ectodomain Is Required for In Vivo Responses to Single Strand DNA. Frontiers in Immunology. 2018-06-27, roč. 9, s. 1491. Dostupné online [cit. 2022-04-28]. ISSN 1664-3224. doi:10.3389/fimmu.2018.01491. PMID 29997629.
  • DIAS, André Alves; SILVA, Carlos Adriano de Matos e; SILVA, Camila Oliveira da. TLR-9 Plays a Role in Mycobacterium leprae-Induced Innate Immune Activation of A549 Alveolar Epithelial Cells. Frontiers in Immunology. 2021-08-12, roč. 12, s. 657449. Dostupné online [cit. 2022-04-28]. ISSN 1664-3224. doi:10.3389/fimmu.2021.657449. PMID 34456901.
  • GROTE, J. Proceedings: Cerebral blood flow during arterial hypoxia. Arzneimittel-Forschung. 1975-10, roč. 25, čís. 10, s. 1673–1674. PMID: 1045. Dostupné online [cit. 2022-04-28]. ISSN 0004-4172. PMID 1045.
  • HAN, Sang Jun; WILLIAMS, Ryan M.; D’AGATI, Vivette. Selective nanoparticle-mediated targeting of renal tubular Toll-like receptor 9 attenuates ischemic acute kidney injury. Kidney International. 2020-07, roč. 98, čís. 1, s. 76–87. Dostupné online [cit. 2022-04-28]. doi:10.1016/j.kint.2020.01.036. PMID 32386967. (anglicky)
  • CHANDLER, Madison R.; KEENE, Kimberly S.; TUOMELA, Johanna M. Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans. PLOS ONE. 2017-09-08, roč. 12, čís. 9, s. e0183832. Dostupné online [cit. 2022-04-28]. ISSN 1932-6203. doi:10.1371/journal.pone.0183832. PMID 28886076. (anglicky)
  • CAI, Yongqing; HUANG, Jian; XING, Haiyan. Contribution of FPR and TLR9 to hypoxia-induced chemoresistance of ovarian cancer cells. OncoTargets and Therapy. 2018-12-28, roč. 12, s. 291–301. Dostupné online [cit. 2022-04-28]. doi:10.2147/OTT.S190118. PMID 30643427. (anglicky)
  • WANG, Shu; ZHUANG, Xibing; GAO, Caixia. Expression of p16, p53, and TLR9 in HPV-Associated Head and Neck Squamous Cell Carcinoma: Clinicopathological Correlations and Potential Prognostic Significance. OncoTargets and Therapy. 2021-02, roč. Volume 14, s. 867–877. Dostupné online [cit. 2022-04-28]. ISSN 1178-6930. doi:10.2147/OTT.S293163. PMID 33574680. (anglicky)

pubmed.ncbi.nlm.nih.gov

  • BECK, Stacy; BUHIMSCHI, Irina A.; SUMMERFIELD, Taryn L. Toll-like receptor 9, maternal cell-free DNA and myometrial cell response to CpG oligodeoxynucleotide stimulation. American Journal of Reproductive Immunology (New York, N.Y.: 1989). 2019-04, roč. 81, čís. 4, s. e13100. PMID: 30758898 PMCID: PMC6453711. Dostupné online [cit. 2022-04-28]. ISSN 1600-0897. doi:10.1111/aji.13100. PMID 30758898.
  • GROTE, J. Proceedings: Cerebral blood flow during arterial hypoxia. Arzneimittel-Forschung. 1975-10, roč. 25, čís. 10, s. 1673–1674. PMID: 1045. Dostupné online [cit. 2022-04-28]. ISSN 0004-4172. PMID 1045.

plos.org (Global: 2,101st place; Czech: 340th place)

dx.plos.org

wiley.com (Global: 150th place; Czech: 67th place)

onlinelibrary.wiley.com

  • WEI, Jingjing; WU, Di; ZHAO, Songsong. Immunotherapy of Malignant Glioma by Noninvasive Administration of TLR9 Agonist CpG Nano‐Immunoadjuvant. Advanced Science. 2022-03-07, s. 2103689. Dostupné online [cit. 2022-04-28]. ISSN 2198-3844. doi:10.1002/advs.202103689. (anglicky)

worldcat.org (Global: 4th place; Czech: 2nd place)

  • Toll and toll-like receptors : an immunologic perspective. Georgetown, Tex.: Landes Bioscience/Eureka.com 1 online resource (218 pages) s. Dostupné online. ISBN 978-0-387-27445-4, ISBN 0-387-27445-6. OCLC 262677553
  • JEONG, Soung Won. Toll-like receptor 9, a possible blocker of non-alcoholic steatohepatitis?. Clinical and Molecular Hepatology. 2020-04-01, roč. 26, čís. 2, s. 185–186. Dostupné online [cit. 2022-04-28]. ISSN 2287-2728. doi:10.3350/cmh.2020.0046. (anglicky)
  • BECK, Stacy; BUHIMSCHI, Irina A.; SUMMERFIELD, Taryn L. Toll-like receptor 9, maternal cell-free DNA and myometrial cell response to CpG oligodeoxynucleotide stimulation. American Journal of Reproductive Immunology (New York, N.Y.: 1989). 2019-04, roč. 81, čís. 4, s. e13100. PMID: 30758898 PMCID: PMC6453711. Dostupné online [cit. 2022-04-28]. ISSN 1600-0897. doi:10.1111/aji.13100. PMID 30758898.
  • SONG, Ying; SHOU, Li Meng; AI, Li-Yao. Mini-Review: The Non-Immune Functions of Toll-Like Receptors. Critical Reviews in Eukaryotic Gene Expression. 2019, roč. 29, čís. 1, s. 37–45. Dostupné online [cit. 2022-04-28]. ISSN 1045-4403. doi:10.1615/CritRevEukaryotGeneExpr.2018027399. (anglicky)
  • SINHA, Siddhartha S.; CAMERON, Jody; BROOKS, James C. Complex Negative Regulation of TLR9 by Multiple Proteolytic Cleavage Events. The Journal of Immunology. 2016-08-15, roč. 197, čís. 4, s. 1343–1352. Dostupné online [cit. 2022-04-28]. ISSN 0022-1767. doi:10.4049/jimmunol.1502357. PMID 27421483. (anglicky)
  • FUKUI, Ryutaro; YAMAMOTO, Chikako; MATSUMOTO, Fumi. Cleavage of Toll-Like Receptor 9 Ectodomain Is Required for In Vivo Responses to Single Strand DNA. Frontiers in Immunology. 2018-06-27, roč. 9, s. 1491. Dostupné online [cit. 2022-04-28]. ISSN 1664-3224. doi:10.3389/fimmu.2018.01491. PMID 29997629.
  • BAI, Ling; CHEN, Wei; CHEN, Jingtao. Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application. Journal of Translational Medicine. 2017-12, roč. 15, čís. 1, s. 51. Dostupné online [cit. 2022-04-28]. ISSN 1479-5876. doi:10.1186/s12967-017-1152-5. (anglicky)
  • DIAS, André Alves; SILVA, Carlos Adriano de Matos e; SILVA, Camila Oliveira da. TLR-9 Plays a Role in Mycobacterium leprae-Induced Innate Immune Activation of A549 Alveolar Epithelial Cells. Frontiers in Immunology. 2021-08-12, roč. 12, s. 657449. Dostupné online [cit. 2022-04-28]. ISSN 1664-3224. doi:10.3389/fimmu.2021.657449. PMID 34456901.
  • MARTÍNEZ-CAMPOS, Cecilia; BURGUETE-GARCÍA, Ana I.; MADRID-MARINA, Vicente. Role of TLR9 in Oncogenic Virus-Produced Cancer. Viral Immunology. 2017-03, roč. 30, čís. 2, s. 98–105. Dostupné online [cit. 2022-04-28]. ISSN 0882-8245. doi:10.1089/vim.2016.0103. (anglicky)
  • GROTE, J. Proceedings: Cerebral blood flow during arterial hypoxia. Arzneimittel-Forschung. 1975-10, roč. 25, čís. 10, s. 1673–1674. PMID: 1045. Dostupné online [cit. 2022-04-28]. ISSN 0004-4172. PMID 1045.
  • ZENG, Xian-Zi; HUANG, Zhan-Sen; FANG, Hong-Peng. Coexpression of TLR9 and VEGF-C is associated with lymphatic metastasis in prostate cancer. Asian Journal of Andrology. 2022, roč. 0, čís. 0, s. 0. Dostupné online [cit. 2022-04-28]. ISSN 1008-682X. doi:10.4103/aja202167. (anglicky)
  • CHANDLER, Madison R.; KEENE, Kimberly S.; TUOMELA, Johanna M. Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans. PLOS ONE. 2017-09-08, roč. 12, čís. 9, s. e0183832. Dostupné online [cit. 2022-04-28]. ISSN 1932-6203. doi:10.1371/journal.pone.0183832. PMID 28886076. (anglicky)
  • GAO, Caixia; QIAO, Tiankui; YUAN, Sujuan. The Preliminary Study for Postoperative Radiotherapy Survival Associated with RUNX3 and TLR9 Expression in Lung Cancer. Cancer Management and Research. 2021-06, roč. Volume 13, s. 4497–4507. Dostupné online [cit. 2022-04-28]. ISSN 1179-1322. doi:10.2147/CMAR.S305452. (anglicky)
  • WEI, Jingjing; WU, Di; ZHAO, Songsong. Immunotherapy of Malignant Glioma by Noninvasive Administration of TLR9 Agonist CpG Nano‐Immunoadjuvant. Advanced Science. 2022-03-07, s. 2103689. Dostupné online [cit. 2022-04-28]. ISSN 2198-3844. doi:10.1002/advs.202103689. (anglicky)
  • WANG, Shu; ZHUANG, Xibing; GAO, Caixia. Expression of p16, p53, and TLR9 in HPV-Associated Head and Neck Squamous Cell Carcinoma: Clinicopathological Correlations and Potential Prognostic Significance. OncoTargets and Therapy. 2021-02, roč. Volume 14, s. 867–877. Dostupné online [cit. 2022-04-28]. ISSN 1178-6930. doi:10.2147/OTT.S293163. PMID 33574680. (anglicky)